FDA NDC Directory · JSON-LD · Markdown

NEUPOGEN

NDC 55513-209 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nameFilgrastim
Labeler / ManufacturerAmgen, Inc
Marketing categoryBiologic License Application · App BLA103353
Dosage form / routeINJECTION, SOLUTION · INTRAVENOUS SUBCUTANEOUS
Active ingredientsFILGRASTIM (480 ug/.8mL)
Marketing started20001002
Package count3

External sources

Source: openFDA. Public-domain (CC0).